Skip to Main Content

Author Details

David L Rimm
Yale University School of Medicine
1980
494
103
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37730017Automated scoring of tumor-infiltrating lymphocytes informs risk of death from thin melanoma: A nested case-case study.J Am Acad Dermatol2024
36394848An Algorithm as a Biomarker for Response to Immune Checkpoint Inhibitor Therapy.JAMA Oncol2023
37586773Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases.J Immunother Cancer2023
37835599Stress Keratin 17 Is a Predictive Biomarker Inversely Associated with Response to Immune Check-Point Blockade in Head and Neck Squamous Cell Carcinomas and Beyond.Cancers (Basel)2023
37781235Digital spatial profiling of melanoma shows CD95 expression in immune cells is associated with resistance to immunotherapy.Oncoimmunology2023
37608772Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerJ Pathol2023
37608771Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.J Pathol2023
37575280Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer.Cancer Res Commun2023
37541244Mammalian SWI/SNF chromatin remodeling complexes promote tyrosine kinase inhibitor resistance in EGFR-mutant lung cancer.Cancer Cell2023
37498606Classification of Breast Cancer According to ERBB2 Immunohistochemistry Scores.JAMA Oncol2023
37057033Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in Head and Neck Squamous Cell Carcinoma.Cancer Res Commun2023
37179362Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trial.NPJ Breast Cancer2023
37105494Multiplex Immunohistochemistry and Immunofluorescence: A Practical Update for Pathologists.Mod Pathol2023
37233452Subsets of IFN Signaling Predict Response to Immune Checkpoint Blockade in Patients with Melanoma.Clin Cancer Res2023
37295047Deep learning-based scoring of tumour-infiltrating lymphocytes is prognostic in primary melanoma and predictive to PD-1 checkpoint inhibition in melanoma metastases.EBioMedicine2023
37264091Deep computational image analysis of immune cell niches reveals treatment-specific outcome associations in lung cancer.NPJ Precis Oncol2023
37093713Assessment of the Impact of Alternative Fixatives on HER2 Detection in Breast Cancer and Gastric Cancer Tumor Specimens.Appl Immunohistochem Mol Morphol2023
36960400Quantitative, Spatially Defined Expression of Leukocyte-associated Immunoglobulin-like Receptor in Non-small Cell Lung Cancer.Cancer Res Commun2023
36925070Tissue Age Affects Antigenicity and Scoring for the 22C3 Immunohistochemistry Companion Diagnostic Test.Mod Pathol2023
36889057Multi-Institutional Study of Pathologist Reading of the Programmed Cell Death Ligand-1 Combined Positive Score Immunohistochemistry Assay for Gastric or Gastroesophageal Junction Cancer.Mod Pathol2023
36788069Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry.Mod Pathol2023
36577091The Pathologists' Conundrum.Arch Pathol Lab Med2023
36894898Spatial characterization and quantification of CD40 expression across cancer types.BMC Cancer2023
34508229Standardization of PD-L1 immunohistochemistry.Mod Pathol2022
35649657Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancer.J Immunother Cancer2022
35581307Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer.Lab Invest2022
35377948Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer.Clin Cancer Res2022
35764237Programmed Death-Ligand 1 and Programmed Death-Ligand 2 mRNAs Measured Using Closed-System Quantitative Real-Time Polymerase Chain Reaction Are Associated With Outcome and High Negative Predictive Value in Immunotherapy-Treated NSCLC.J Thorac Oncol2022
35793873Quantitative tissue analysis and role of myeloid cells in non-small cell lung cancer.J Immunother Cancer2022
35640927Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma.J Immunother Cancer2022
35398219Not all well-differentiated cutaneous squamous cell carcinomas are equal: Tumors with disparate biologic behavior have differences in protein expression via digital spatial profiling.J Am Acad Dermatol2022
35490853Discovery of Biomarkers of Resistance to Immune Checkpoint Blockade in NSCLC Using High-Plex Digital Spatial Profiling.J Thorac Oncol2022
35459795Development of an immunohistochemical assay for Siglec-15.Lab Invest2022
35661148Image analysis reveals molecularly distinct patterns of TILs in NSCLC associated with treatment outcome.NPJ Precis Oncol2022
35595825Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer.Lab Invest2022
35816627Ki67 as a Companion Diagnostic: Good or Bad News?J Clin Oncol2022
35810563Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms.EBioMedicine2022
36522538Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockade.NPJ Precis Oncol2022
36446042Proceedings From the ASCO/College of American Pathologists Immune Checkpoint Inhibitor Predictive Biomarker Summit.JCO Precis Oncol2022
36444764The Effect of Black Cohosh on Ki67 expression and Tumor Volume: A Pilot Study of Ductal Carcinoma in Situ Patients.Integr Cancer Ther2022
36002182Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer.J Immunother Cancer2022
36313654Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance.Front Oncol2022
35903931Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBC.Clin Cancer Res2022
35869114Tumor immune microenvironment of self-identified African American and non-African American triple negative breast cancer.NPJ Breast Cancer2022
34921525What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study.Cancer Med2022
35256599Impact of a randomized weight loss trial on breast tissue markers in breast cancer survivors.NPJ Breast Cancer2022
35219026Inhibition of renalase drives tumour rejection by promoting T cell activation.Eur J Cancer2022
35115541Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer.NPJ Breast Cancer2022
35113160Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue.JAMA Oncol2022
35108062CECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppression.Sci Transl Med2022
  • 1 - 50 of 494

Recommended Authors

Zhengming Chen
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 7
Mich??le Orain
Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Universite Laval
Career Start Year 2013
Number of shared co-authors 4
Juan Moreno
University of Toronto
Career Start Year 2011
Number of shared co-authors 0
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 8
Karolina Edlund
Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund
Career Start Year 2008
Number of shared co-authors 5
Elton Rexhepaj
UCD Conway Institute, University College Dublin
Career Start Year 2007
Number of shared co-authors 5
Caterina Marchi??
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Career Start Year 2005
Number of shared co-authors 11
Esther Herpel
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 15
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2004
Number of shared co-authors 29
Danh Tran-Thanh
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2002
Number of shared co-authors 2
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 31
Nicola Fusco
IEO European Institute of Oncology IRCCS
Career Start Year 2002
Number of shared co-authors 5
Darran P O'Connor
UCD Conway Institute, University College Dublin
Career Start Year 2001
Number of shared co-authors 8
Anna Asplund
Uppsala University
Career Start Year 2001
Number of shared co-authors 5
Steve E Kalloger
University of British Columbia
Career Start Year 2000
Number of shared co-authors 4
Christopher J Howlett
Western University
Career Start Year 1999
Number of shared co-authors 3
Patrick Micke
Uppsala University
Career Start Year 1997
Number of shared co-authors 4
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 9
Robert Kim
University of California
Career Start Year 1996
Number of shared co-authors 5
Susan J Done
University Health Network
Career Start Year 1994
Number of shared co-authors 4
William J Howat
Cancer Research UK Cambridge Institute
Career Start Year 1994
Number of shared co-authors 14
Paul N Span
Radboud University Medical Center
Career Start Year 1993
Number of shared co-authors 8
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 1
Rosemary L Balleine
Westmead Institute for Medical Research, The University of Sydney
Career Start Year 1993
Number of shared co-authors 14
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 40
Fredrik Pont??n
Uppsala University
Career Start Year 1991
Number of shared co-authors 10
Keith A Baggerly
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 11
Katherine Stemke-Hale
MD Anderson Cancer Center, University of Texas
Career Start Year 1989
Number of shared co-authors 14
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 10
Silvano Bosari
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 3

Collaborators

Harriet M Kluger
Yale School of Medicine
Co-authored papers 48
Lajos Pusztai
Co-authored papers 32
Roy S Herbst
Yale School of Medicine
Co-authored papers 29
Yuval Kluger
Yale University School of Medicine
Co-authored papers 17
Christos Sotiriou
Co-authored papers 12
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Co-authored papers 11
John M S Bartlett
University of Edinburgh
Co-authored papers 9
Annette M Molinaro
Co-authored papers 9
Sandra Demaria
Weill Cornell Medical College
Co-authored papers 9
Mark E Sherman
Mayo Clinic
Co-authored papers 8
Justin M Balko
Co-authored papers 8
William F Symmans
Co-authored papers 8
Richard P Lifton
The Rockefeller University
Co-authored papers 8
Allison Welsh
Exact Sciences Corporation
Co-authored papers 7
Melinda E Sanders
Co-authored papers 7
Xiaohong R Yang
National Cancer Institute
Co-authored papers 6
Christos Hatzis
Co-authored papers 6
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Co-authored papers 5
Montserrat Garcia-Closas
National Cancer Institute
Co-authored papers 5
Frederick Klauschen
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Co-authored papers 5
Jolanta Lissowska
The M. Sklodowska-Curie Cancer Center and Institute of Oncology
Co-authored papers 5
Eric B Rimm
Harvard T.H. Chan School of Public Health
Co-authored papers 5
Paula I Gonzalez-Ericsson
Co-authored papers 5
Sunil R Lakhani
University of Queensland
Co-authored papers 4
Jonine D Figueroa
The Usher Institute, The University of Edinburgh
Co-authored papers 4
Louise A Brinton
National Cancer Institute
Co-authored papers 4
Alexander J Lazar
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Marcus Bosenberg
Yale School of Medicine
Co-authored papers 4
Paul J van Diest
University Medical Center Utrecht
Co-authored papers 4
Katherine L Nathanson
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Co-authored papers 4
Release 1.2